单个氨基酸调节LL-37和HNP1之间的抗菌合作性
Ariane M Schwitter1, Takashi Yasuda2, Xiang Li2
1Institute of Industrial Science, The University of Tokyo, 4-6-1 Komaba Meguro-Ku, Tokyo 153-8505, Japan.
Langmuir : the ACS journal of surfaces and colloids
|January 15, 2026
概括
人类抗微生物 (AMP),如LL-37和防御素,对抗性细菌表现出协同作用. 防御性N-终端是这种合作相互作用的关键,增强杀死细菌和减少宿主毒性.
科学领域:
- 生物化学 生物化学
- 微生物学 微生物学
- 结构生物学 结构生物学
背景情况:
- 抗微生物 (AMP) 在对抗多药耐药细菌感染方面至关重要.
- 人类AMPLL-37和α-defensin (HNP1) 显示出协同作用,增强杀死细菌并降低宿主细胞毒性.
- 这种LL-37与 defensins之间的合作现象的结构基础尚不清楚.
研究的目的:
- 调查LL-37与各种防御系统之间的合作效应背后的结构功能关系.
- 确定LL-37和HNP1之间观察到的合作效应是特定的还是扩展到其他防御素家族成员.
- 确定负责调节与LL-37的协同相互作用的防御蛋白内的特定区域.
主要方法:
- 进行了膜毒性测定,以评估LL-37与不同防御素 (HNP1,HNP3,HNP4,hBD1,HNP2) 之间的相互作用.
- 对各种防御素的氨基酸序列进行了比较分析.
- 结构-活性关系研究的重点是 defensins 的 N-终端区域.
主要成果:
- 通过HNP1对POPC膜的LL-37中和的合作效应观察到HNP3,HNP4和hBD1,但不是HNP2.
- 防御素的N端区域被确定为与LL-37.7合作效应的关键调节器.
- 在N端的特定氨基酸变异与协同作用相互作用的存在或不存在相关.
结论:
- LL-37与防御蛋白之间的合作相互作用不仅仅局限于HNP1,而是某些防御蛋白家族成员的更广泛的特性.
- 防御素的N端在与LL-37结合时,在调解协同抗微生物活性和降低细胞毒性方面发挥着关键作用.
- 了解这种结构功能关系可以指导开发基于AMP的新型治疗方法.
更多相关视频
相关概念视频
Cooperative Allosteric Transitions
8.6K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.6K
Ligand Binding Sites
14.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.9K
Antimicrobial Proteins
13.0K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
13.0K
Covalently Linked Protein Regulators
8.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.7K
Ligand Binding and Linkage
5.5K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.5K


